R-EPOCH+ VENETOKLAKS

Kaynaklar:

1- Davids MS, Huang Y, Rogers KA, et al. Richter’s syndrome (RS) in patients with chronic lymphocytic leukemia (CLL) on novel agent therapy. J Clin Oncol. 2017;35(15 suppl):7505.

2- Rogers KA, Huang Y, Ruppert AS, et al. A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor. Br J Haematol. 2018;180(2):259-266.

3- Davids MS Rogers KA Tyekucheva S et al. A multicenter phase II study of venetoclax plus dose-adjusted R-EPOCH (VR-EPOCH) for Richter's syndrome. Proc Am Soc Clin Oncol. 2020; 38 (abstr).8004